S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Laser breakthrough could send stock soaring 2,467% (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Laser breakthrough could send stock soaring 2,467% (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Our #1 Laser Stock for May (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Laser breakthrough could send stock soaring 2,467% (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Laser breakthrough could send stock soaring 2,467% (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Our #1 Laser Stock for May (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Laser breakthrough could send stock soaring 2,467% (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Laser breakthrough could send stock soaring 2,467% (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Our #1 Laser Stock for May (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Laser breakthrough could send stock soaring 2,467% (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Laser breakthrough could send stock soaring 2,467% (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
Our #1 Laser Stock for May (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
NASDAQ:SILK

Silk Road Medical (SILK) Stock Forecast, Price & News

$31.95
+0.52 (+1.65%)
(As of 06/9/2023 ET)
Compare
Today's Range
$31.19
$32.18
50-Day Range
$29.76
$46.14
52-Week Range
$28.98
$58.04
Volume
500,586 shs
Average Volume
606,139 shs
Market Capitalization
$1.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.25

Silk Road Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
51.0% Upside
$48.25 Price Target
Short Interest
Healthy
9.01% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.57mentions of Silk Road Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.58 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.53) to ($1.36) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

259th out of 987 stocks

Surgical & Medical Instruments Industry

25th out of 95 stocks


SILK stock logo

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock News Headlines

Citi Keeps Their Buy Rating on Cooper Co (COO)
Johnson & Johnson (JNJ) Receives a New Rating from Citi
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Stifel Nicolaus Remains a Buy on Silk Road Medical (SILK)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Stifel Nicolaus Keeps Their Buy Rating on Silk Road Medical (SILK)
Expert Ratings for Silk Road Medical
See More Headlines

SILK Price History

SILK Company Calendar

Last Earnings
5/09/2023
Today
6/10/2023
Next Earnings (Estimated)
7/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$48.25
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+51.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$-55,010,000.00
Pretax Margin
-36.35%

Debt

Sales & Book Value

Annual Sales
$138.64 million
Book Value
$4.30 per share

Miscellaneous

Free Float
36,134,000
Market Cap
$1.24 billion
Optionable
Not Optionable
Beta
1.18

Key Executives

  • Erica J. RogersErica J. Rogers
    President, Chief Executive Officer & Director
  • Lucas W. BuchananLucas W. Buchanan
    Chief Financial & Operating Officer
  • Sumaira Macdonald
    Executive Director-Medical
  • Tammy Leitsinger
    VP-Professional Education & Medical Affairs
  • William Whealon
    Executive Vice President-Research & Development













SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SILK shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2023?

5 brokerages have issued 1 year price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $27.00 to $60.00. On average, they predict the company's stock price to reach $48.25 in the next twelve months. This suggests a possible upside of 51.0% from the stock's current price.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2023?

Silk Road Medical's stock was trading at $52.85 at the beginning of 2023. Since then, SILK shares have decreased by 39.5% and is now trading at $31.95.
View the best growth stocks for 2023 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by $0.04. The firm had revenue of $40.13 million for the quarter, compared to the consensus estimate of $40.69 million. Silk Road Medical had a negative net margin of 36.47% and a negative trailing twelve-month return on equity of 50.13%. The firm's revenue for the quarter was up 43.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.48) EPS.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $176.00 million-$184.00 million, compared to the consensus revenue estimate of $180.27 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (8.38%), BlackRock Inc. (6.93%), Clearbridge Investments LLC (4.46%), Kayne Anderson Rudnick Investment Management LLC (3.54%), American Century Companies Inc. (3.51%) and Fred Alger Management LLC (2.64%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Richard Ruedy and Tony M Chou.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $31.95.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.24 billion and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.50) on an earnings per share basis.

How many employees does Silk Road Medical have?

The company employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -